Update on DXA reporting and treatments for osteoporosis

Add to CPD Start a discussion

The treatment pathway for postmeonopausal women with osteoporosis has changed with the emergence of two new anabolic treatments approved by NICE (romosozumab and abaloparatide). This teaching will educate practitioners about which patients should be considered for these treatments over oral bisphosphonates.


Speaker(s)

Dr Vera Choida



Broadcast date: March 28th, 2025
Review date: Apr 1st, 2027